Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome
Juan Wang, Shuangyong Dong, Mengjuan Fang, Zhiyan Fan, Yuansheng Xu Department of Emergency, Affiliated Hangzhou First People`s Hospital, School of Medicine, Westlake University, Hangzhou, People’s Republic of ChinaCorrespondence: Yuansheng Xu, Department of Emergency, Affiliated Hangzhou First Peop...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-01-01
|
| Series: | Infection and Drug Resistance |
| Subjects: | |
| Online Access: | https://www.dovepress.com/omadacycline-for-the-treatment-of-severe-chlamydia-psittaci-pneumoni-2-peer-reviewed-fulltext-article-IDR |
| _version_ | 1827384360939028480 |
|---|---|
| author | Wang J Dong S Fang M Fan Z Xu Y |
| author_facet | Wang J Dong S Fang M Fan Z Xu Y |
| author_sort | Wang J |
| collection | DOAJ |
| description | Juan Wang, Shuangyong Dong, Mengjuan Fang, Zhiyan Fan, Yuansheng Xu Department of Emergency, Affiliated Hangzhou First People`s Hospital, School of Medicine, Westlake University, Hangzhou, People’s Republic of ChinaCorrespondence: Yuansheng Xu, Department of Emergency, Affiliated Hangzhou First People`s Hospital, School of Medicine, Westlake University, No. 261 Huansha Road, Hangzhou, Zhejiang Province, 310006, People’s Republic of China, Email xys0912@163.comBackground: Chlamydia psittaci (C. psittaci) is a pathogen that is seldom implicated in community-acquired pneumonia and is rarely linked to severe pneumonia. Reports of severe C. psittaci pneumonia accompanied by Guillain-Barre syndrome (GBS) are scarce. Tetracyclines are the preferred therapeutic approach for psittacosis. Omadacycline, a novel tetracycline, demonstrates strong antibacterial efficacy against typical bacteria and atypical pathogens, including C. psittaci. However, its application in the treatment of psittacosis pneumonia remains constrained.Case Presentation: A 77-year-old female patient was admitted to the hospital presenting with symptoms of fever, low back pain, and headache. The diagnosis of C. psittaci was established through the utilization of metagenomic next-generation sequencing (mNGS). Initial administration of moxifloxacin, meropenem, piperacillin-tazobactam, and doxycycline proved to be ineffective. Subsequent omadacycline leaded to the successful resolution of fever and dyspnea. However, after the endotracheal tube was removed, the patient experienced a rapid decline in symmetrical limb strength, leading to a diagnosis of GBS based on clinical manifestations, cerebrospinal fluid analysis, and electromyography. Following a 5-day course of immunoglobulin therapy and nutritional nerve treatment, the patient’s condition ameliorated, culminating in an uncomplicated discharge.Conclusion: This case provides evidence supporting the potential use of omadacycline as a therapeutic option for the treatment of severe C. psittaci pneumonia. The utilization of mNGS technology is of paramount importance in the prompt identification of uncommon pathogens, including C. psittaci. Nevertheless, the occurrence of GBS should be taken into consideration when C. psittaci pneumonia is accompanied by symmetrical limb weakness. These findings have important implications for the diagnosis, treatment, and management of patients with C. psittaci pneumonia.Keywords: Chlamydia psittaci pneumonia, Guillain-Barre syndrome, omadacycline, metagenomic next‑generation sequencing |
| first_indexed | 2024-03-08T14:54:25Z |
| format | Article |
| id | doaj.art-7fe5898fd8b74b9099d14a349a589f20 |
| institution | Directory Open Access Journal |
| issn | 1178-6973 |
| language | English |
| last_indexed | 2024-03-08T14:54:25Z |
| publishDate | 2024-01-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Infection and Drug Resistance |
| spelling | doaj.art-7fe5898fd8b74b9099d14a349a589f202024-01-10T18:05:59ZengDove Medical PressInfection and Drug Resistance1178-69732024-01-01Volume 17818789593Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre SyndromeWang JDong SFang MFan ZXu YJuan Wang, Shuangyong Dong, Mengjuan Fang, Zhiyan Fan, Yuansheng Xu Department of Emergency, Affiliated Hangzhou First People`s Hospital, School of Medicine, Westlake University, Hangzhou, People’s Republic of ChinaCorrespondence: Yuansheng Xu, Department of Emergency, Affiliated Hangzhou First People`s Hospital, School of Medicine, Westlake University, No. 261 Huansha Road, Hangzhou, Zhejiang Province, 310006, People’s Republic of China, Email xys0912@163.comBackground: Chlamydia psittaci (C. psittaci) is a pathogen that is seldom implicated in community-acquired pneumonia and is rarely linked to severe pneumonia. Reports of severe C. psittaci pneumonia accompanied by Guillain-Barre syndrome (GBS) are scarce. Tetracyclines are the preferred therapeutic approach for psittacosis. Omadacycline, a novel tetracycline, demonstrates strong antibacterial efficacy against typical bacteria and atypical pathogens, including C. psittaci. However, its application in the treatment of psittacosis pneumonia remains constrained.Case Presentation: A 77-year-old female patient was admitted to the hospital presenting with symptoms of fever, low back pain, and headache. The diagnosis of C. psittaci was established through the utilization of metagenomic next-generation sequencing (mNGS). Initial administration of moxifloxacin, meropenem, piperacillin-tazobactam, and doxycycline proved to be ineffective. Subsequent omadacycline leaded to the successful resolution of fever and dyspnea. However, after the endotracheal tube was removed, the patient experienced a rapid decline in symmetrical limb strength, leading to a diagnosis of GBS based on clinical manifestations, cerebrospinal fluid analysis, and electromyography. Following a 5-day course of immunoglobulin therapy and nutritional nerve treatment, the patient’s condition ameliorated, culminating in an uncomplicated discharge.Conclusion: This case provides evidence supporting the potential use of omadacycline as a therapeutic option for the treatment of severe C. psittaci pneumonia. The utilization of mNGS technology is of paramount importance in the prompt identification of uncommon pathogens, including C. psittaci. Nevertheless, the occurrence of GBS should be taken into consideration when C. psittaci pneumonia is accompanied by symmetrical limb weakness. These findings have important implications for the diagnosis, treatment, and management of patients with C. psittaci pneumonia.Keywords: Chlamydia psittaci pneumonia, Guillain-Barre syndrome, omadacycline, metagenomic next‑generation sequencinghttps://www.dovepress.com/omadacycline-for-the-treatment-of-severe-chlamydia-psittaci-pneumoni-2-peer-reviewed-fulltext-article-IDRchlamydia psittaci pneumoniaguillain-barre syndromeomadacyclinemetagenomic next‑generation sequencing |
| spellingShingle | Wang J Dong S Fang M Fan Z Xu Y Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome Infection and Drug Resistance chlamydia psittaci pneumonia guillain-barre syndrome omadacycline metagenomic next‑generation sequencing |
| title | Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome |
| title_full | Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome |
| title_fullStr | Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome |
| title_full_unstemmed | Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome |
| title_short | Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Guillain-Barre Syndrome |
| title_sort | omadacycline for the treatment of severe chlamydia psittaci pneumonia complicated with guillain barre syndrome |
| topic | chlamydia psittaci pneumonia guillain-barre syndrome omadacycline metagenomic next‑generation sequencing |
| url | https://www.dovepress.com/omadacycline-for-the-treatment-of-severe-chlamydia-psittaci-pneumoni-2-peer-reviewed-fulltext-article-IDR |
| work_keys_str_mv | AT wangj omadacyclineforthetreatmentofseverechlamydiapsittacipneumoniacomplicatedwithguillainbarresyndrome AT dongs omadacyclineforthetreatmentofseverechlamydiapsittacipneumoniacomplicatedwithguillainbarresyndrome AT fangm omadacyclineforthetreatmentofseverechlamydiapsittacipneumoniacomplicatedwithguillainbarresyndrome AT fanz omadacyclineforthetreatmentofseverechlamydiapsittacipneumoniacomplicatedwithguillainbarresyndrome AT xuy omadacyclineforthetreatmentofseverechlamydiapsittacipneumoniacomplicatedwithguillainbarresyndrome |